FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Procainamide Hydrochloride Injection, USP
Status: Currently in Shortage
»Date first posted: 09/27/2016
»Therapeutic Categories: Cardiovascular; Renal

Expand all

Amphastar Pharmaceuticals, Inc./IMS (New 04/27/2017)

Company Contact Information:
800-423-4136

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg/1 mL injection; 10 mL Luer-Jet Prefilled Syringe (NDC 76329-3399-5) Available Other

Hospira, Inc. (Revised 09/21/2017)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg/mL; 1,000 mg/10 mL Multiple Dose Glass Fliptop Vial (NDC 0409-1902-01) Next delivery: January 2018; Estimated recovery: 1Q 2018 Shortage per manufacturer: Manufacturing Delay. Other
500 mg/mL; 1,000 mg/2 mL Multiple Dose Glass Fliptop Vial (NDC 0409-1903-01) Limited Supply Available Shortage per manufacturer: Manufacturing Delay. Other

Nexus Pharmaceuticals, Inc. (New 10/19/2017)

Company Contact Information:
888-806-4606

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg/mL, 2 mL (NDC 14789-900-02) Available Other
100 mg/mL, 10 mL (NDC 14789-900-10) Available Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English